Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
Eva Hellström‐Lindberg(Karolinska Institutet), Peter L. Greenberg(Stanford University), Richard S. Stein(Vanderbilt Health), J W Vardiman(University of Chicago Medical Center), Åke Öst(Synlab Czech (Czechia)), Sanford B. Krantz(Vanderbilt Health), Robert S. Negrin(Stanford Medicine), Greger Lindberg(Karolinska Institutet)
Cited by 314
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
|PubMed|1991|765
World Gastroenterology Organisation Global Guideline
|Journal of Clinical Gastroenterology|2011|539
Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis
|Acta Paediatrica|1991|449